Microbiological Monitoring in Therapeutic Trials in Chronic Obstructive Pulmonary Disease
- PMID: 37734068
- PMCID: PMC10867926
- DOI: 10.1164/rccm.202307-1214LE
Microbiological Monitoring in Therapeutic Trials in Chronic Obstructive Pulmonary Disease
Comment in
-
Reply to Martinez-Garcia et al. and to Wang et al.Am J Respir Crit Care Med. 2023 Nov 15;208(10):1144-1145. doi: 10.1164/rccm.202309-1604LE. Am J Respir Crit Care Med. 2023. PMID: 37734070 Free PMC article. No abstract available.
Comment on
-
A Double-Blind, Randomized, Placebo-controlled Trial of Long-Term Doxycycline Therapy on Exacerbation Rate in Patients with Stable Chronic Obstructive Pulmonary Disease.Am J Respir Crit Care Med. 2023 Sep 1;208(5):549-558. doi: 10.1164/rccm.202212-2287OC. Am J Respir Crit Care Med. 2023. PMID: 37450935 Free PMC article. Clinical Trial.
References
-
- Allinson JP, Vlies BH, Brill SE, Law M, Burnside G, Finney LJ, et al. A double-blind, randomized, placebo-controlled trial of long-term doxycycline therapy on exacerbation rate in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med . 2023;208:549–558. - PMC - PubMed
-
- Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med . 2019;200:e45–e67. - PMC - PubMed
-
- Martinez-Garcia MA, Faner R, Oscullo G, de la Rosa D, Soler-Cataluña JJ, Ballester M, et al. Inhaled steroids, circulating eosinophils, chronic airway infection, and pneumonia risk in chronic obstructive pulmonary disease. A network analysis. Am J Respir Crit Care Med . 2020;201:1078–1085. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
